Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1288, pseudogene (RNU6-1288P) is a non-coding RNA-derived pseudogene found in the human genome. It represents a copy of the U6 small nuclear RNA gene (snRNA), which is normally a component of the spliceosome machinery essential for post-transcriptional mRNA splicing[3][7]. U6 snRNA is highly conserved and involved in the splicing of pre-mRNA, but RNU6-1288P is a pseudogene—a non-functional genetic element that does not produce active RNA or protein. Pseudogenes like RNU6-1288P have no established biological role, do not participate directly in molecular or cellular regulatory processes, and are typically artifacts of genome evolution or duplication[1][4][5][6]. RNU6-1288P should not be described as a receptor, enzyme, or transporter; any implication that it is a druggable target is incorrect. Its sequence is cataloged in gene databases for completeness but lacks recognized function in human disease or therapy[1][4][5][6].
None. Drugs do not target pseudogenes for therapeutic action
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1288, pseudogene (RNU6-1288P).